Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients
NCT06154668
·
clinicaltrials.gov ↗
RECRUITING
Status
707
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Sponsor
University Hospital, Grenoble
Collaborators
[object Object]